
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory sync... Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0399 | -7.67307692308 | 0.52 | 0.546 | 0.46 | 2394328 | 0.49688545 | CS |
4 | -0.2199 | -31.4142857143 | 0.7 | 0.779 | 0.45 | 2151993 | 0.58611593 | CS |
12 | -0.1581 | -24.7727984958 | 0.6382 | 0.9799 | 0.45 | 2004881 | 0.678917 | CS |
26 | -0.3709 | -43.5840188014 | 0.851 | 1.07 | 0.45 | 1644936 | 0.71175344 | CS |
52 | -0.7399 | -60.6475409836 | 1.22 | 1.41 | 0.45 | 2334566 | 0.74221965 | CS |
156 | -3.8599 | -88.9377880184 | 4.34 | 5.43 | 0.45 | 2193637 | 1.56837851 | CS |
260 | -1.6999 | -77.9770642202 | 2.18 | 24.9 | 0.45 | 6399290 | 6.72974623 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.